Fingerprint
Dive into the research topics of 'Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically